Compare ProShares Ultra Gold ETF (UGL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Ultra Gold ETF vs GeneDx Holdings Corp — how do they compare? ProShares Ultra Gold ETF trades at $51.9, while GeneDx Holdings Corp trades at $82 (market cap $2.44B). Which is the better fit depends on your goals.
| UGL | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $85.62 | $167.51 |
52-Week Low | $34.37 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UGL is trading at $52.35, up 1.24% with a bullish technical signal from moving averages. The stock shows strong momentum indicators but overbought RSI readings suggest potential near-term consolidation. Recent gold market strength driven by inflation data and geopolitical tensions provides positive sector tailwinds.
The outlook remains positive given gold's safe-haven appeal amid economic uncertainty, though overbought technical conditions warrant caution. Key risks include Federal Reserve policy shifts and gold price volatility. Analyst sentiment appears constructive given the favorable gold market backdrop and institutional demand.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
